Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in H...

Source: BMC Cancer - February 15, 2021 Category: Cancer & Oncology Authors: Li Zhang, Hao Niu, Ping Yang, Jie Ma, Bao-Ying Yuan, Zhao-Chong Zeng and Zuo-Lin Xiang Tags: Research article Source Type: research